Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Oric Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +11 vs. Q2 2024
- Shares held
- 69.8M
- +8.01M (+13.0%) vs. Q2 2024
- Total value
- $715.1M
- +$278.1M (+63.6%) vs. Q2 2024
- New holders
- 24
- 38 more added
- Sold out
- 13
- 39 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Silverarc Capital Management, LLC | 1,099,490 | $11.3M | 2.54% | +23,678+2.2% | Added |
| Price T Rowe Associates Inc | 1,114,885 | $11.4M | 0.00% | −74,342−6.3% | Reduced |
| Balyasny Asset Management LLC | 1,131,066 | $11.6M | 0.03% | +1,131,066 | New |
| Geode Capital Management, LLC | 1,273,513 | $13.1M | 0.00% | +50,821+4.2% | Added |
| Vivo Capital, LLC | 1,277,818 | $13.1M | 1.08% | +8,142+0.6% | Added |
| ArrowMark Colorado Holdings LLC | 1,354,508 | $13.9M | 0.18% | +80,986+6.4% | Added |
| Avidity Partners Management LP | 1,447,119 | $14.8M | 0.76% | +1,447,119 | New |
| First Turn Management, LLC | 1,451,037 | $14.9M | 2.35% | −64,923−4.3% | Reduced |
| NEA Management Company, LLC | 1,500,000 | $15.4M | 0.84% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,732,571 | $17.8M | 0.87% | 00.0% | Unchanged |
| State Street Corp | 1,938,169 | $19.9M | 0.00% | −318,059−14.1% | Reduced |
| Commodore Capital LP | 2,000,000 | $20.5M | 1.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,167,311 | $32.5M | 0.00% | −32,415−1.0% | Reduced |
| EcoR1 Capital, LLC | 3,418,068 | $35.0M | 1.20% | 00.0% | Unchanged |
| The Column Group LLC | 3,540,777 | $36.3M | 52.16% | 00.0% | Unchanged |
| Alkeon Capital Management LLC | 3,904,096 | $40.0M | 0.22% | +100,000+2.6% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,000,000 | $41.0M | 0.15% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 4,142,855 | $42.5M | 1.70% | 00.0% | Unchanged |
| FMR LLC | 4,378,819 | $44.9M | 0.00% | −541,541−11.0% | Reduced |
| VR Adviser, LLC | 4,394,527 | $45.0M | 2.36% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,101,817 | $52.3M | 0.00% | +5,101,817 | New |
| Nextech Invest AG | 5,285,714 | $54.2M | 7.61% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −287,100−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −163,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −96,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −81,227−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −36,901−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −36,223−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −36,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −33,391−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −22,815−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −19,723−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −12,241−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,105−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −661−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Invus Financial Advisors, LLC | – | – | – | – | Not filed |